Monoclonal antibody therapeutics: history and future
Top Cited Papers
- 1 October 2012
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 12 (5), 615-622
- https://doi.org/10.1016/j.coph.2012.08.001
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesNature Biotechnology, 2012
- Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood–brain barrierNeuroscience, 2011
- Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potentialNature Communications, 2011
- Immunogenicity of protein therapeutics: The key causes, consequences and challengesSelf/Nonself, 2010
- Impact of Glycosylation on Effector Functions of Therapeutic IgGPharmaceuticals, 2010
- IgG‐single chain Fv fusion protein therapeutic for alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkeyBiotechnology & Bioengineering, 2009
- Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNSBMC Neuroscience, 2008
- Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display LibraryNature Biotechnology, 1996
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986